Cargando…
Pathway-specific polygenic risk scores correlate with clinical status and Alzheimer’s-related biomarkers
BACKGROUND: APOE is the largest genetic risk factor for sporadic Alzheimer’s disease (AD), but there is a substantial polygenic component as well. Polygenic risk scores (PRS) can summarize small effects across the genome but may obscure differential risk associated with different molecular processes...
Autores principales: | Schork, Nicholas J., Elman, Jeremy A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Journal Experts
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10002839/ https://www.ncbi.nlm.nih.gov/pubmed/36909609 http://dx.doi.org/10.21203/rs.3.rs-2583037/v1 |
Ejemplares similares
-
Associations of Polygenic Risk Score for Late-Onset Alzheimer's Disease With Biomarkers
por: Li, Qiaojun, et al.
Publicado: (2022) -
Improving the Utility of Polygenic Risk Scores as a Biomarker for Alzheimer’s Disease
por: Vlachakis, Dimitrios, et al.
Publicado: (2021) -
Effect of Pathway-specific Polygenic Risk Scores for Alzheimer’s Disease (AD) on Rate of Change in Cognitive Function and AD-related Biomarkers among Asymptomatic Individuals
por: Xu, Yuexuan, et al.
Publicado: (2023) -
Polygenic risk and hazard scores for Alzheimer's disease prediction
por: Leonenko, Ganna, et al.
Publicado: (2019) -
Exploring the genetic heterogeneity of Alzheimer’s disease: Evidence for genetic subtypes
por: Elman, Jeremy A., et al.
Publicado: (2023)